"1214-8687" . "10" . "Therapeutically inevitable progression of malignant neoplasm and its previous cancer treatment, the patient graduated, are a common cause of sudden deterioration of the general condition of the patient. One of the most serious symptom is shortness of breath. Author 's communication deals with dyspnea appearing on the basis of malignant fluidothorax including the possibility of treatment in patients enrolled in the program of palliative cancer care."@en . . "Malign\u00ED fluidothorax u nemocn\u00FDch v programu paliativn\u00ED onkologick\u00E9 p\u00E9\u010De" . . "2"^^ . . "Malignant fluidothorax in patients enrolled in the program of palliative cancer care"@en . "CZ - \u010Cesk\u00E1 republika" . . . . . "Malignant fluidothorax in patients enrolled in the program of palliative cancer care"@en . "Malign\u00ED fluidothorax u nemocn\u00FDch v programu paliativn\u00ED onkologick\u00E9 p\u00E9\u010De"@cs . "1"^^ . "I" . . "1"^^ . "[EFC60A8A9D9E]" . "Malign\u00ED fluidothorax u nemocn\u00FDch v programu paliativn\u00ED onkologick\u00E9 p\u00E9\u010De" . . . "Malign\u00ED fluidothorax u nemocn\u00FDch v programu paliativn\u00ED onkologick\u00E9 p\u00E9\u010De"@cs . "L\u00E9\u010Debn\u011B neodvratiteln\u00E1 progrese zhoubn\u00E9ho novotvaru a jeho p\u0159edchoz\u00ED protin\u00E1dorov\u00E1 l\u00E9\u010Dba, kterou pacient absolvoval, jsou \u010Dastou p\u0159\u00ED\u010Dinou n\u00E1hl\u00E9ho zhor\u0161en\u00ED celkov\u00E9ho stavu pacienta. Jedn\u00EDm z velmi z\u00E1va\u017En\u00FDch symptom\u016F je du\u0161nost. Autor se ve sv\u00E9m sd\u011Blen\u00ED zab\u00FDv\u00E1 problematikou du\u0161nosti vznikl\u00E9 na podklad\u011B malign\u00EDho fluidothoraxu v\u010Detn\u011B mo\u017Enost\u00ED jeho l\u00E9\u010Dby u nemocn\u00FDch za\u0159azen\u00FDch do programu palitivn\u00ED onkologick\u00E9 p\u00E9\u010De."@cs . . . "http://www.medicinapropraxi.cz/pdfs/med/2013/01/07.pdf" . . . "Medic\u00EDna pro praxi" . "L\u00E9\u010Debn\u011B neodvratiteln\u00E1 progrese zhoubn\u00E9ho novotvaru a jeho p\u0159edchoz\u00ED protin\u00E1dorov\u00E1 l\u00E9\u010Dba, kterou pacient absolvoval, jsou \u010Dastou p\u0159\u00ED\u010Dinou n\u00E1hl\u00E9ho zhor\u0161en\u00ED celkov\u00E9ho stavu pacienta. Jedn\u00EDm z velmi z\u00E1va\u017En\u00FDch symptom\u016F je du\u0161nost. Autor se ve sv\u00E9m sd\u011Blen\u00ED zab\u00FDv\u00E1 problematikou du\u0161nosti vznikl\u00E9 na podklad\u011B malign\u00EDho fluidothoraxu v\u010Detn\u011B mo\u017Enost\u00ED jeho l\u00E9\u010Dby u nemocn\u00FDch za\u0159azen\u00FDch do programu palitivn\u00ED onkologick\u00E9 p\u00E9\u010De." . . "RIV/00179906:_____/13:10190803" . "patient; malignant fluidothorax; dyspnea; palliative cancer care"@en . "85833" . "Slov\u00E1\u010Dek, Ladislav" . "RIV/00179906:_____/13:10190803!RIV14-MZ0-00179906" . "1" . .